DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell AW, Du MQ, Luan SL, Altmann DR, Thompson AJ, Compston A, Scott MA, Miller DH, Chandran S.
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.
Lancet Neurol 2012;
11: 150-156
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.